http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20090424-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eb9667071f40bd09df47436437f0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
filingDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0d2763ca12a3658228f7bd3745d1b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fe8613f4670f4c3bc87bb905910c5a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16176b1b1ea38db0ddc483dea7e922f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b776ba7a9cde3ad26a766718c0820a71
publicationDate 2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20090424-T1
titleOfInvention PROCEDURE FOR THE TREATMENT OF ATHEROSCLEROSIS, DISLIPIDEMIA AND RELATED CONDITIONS AND PHARMACEUTICAL COMPOSITION
abstract A pharmaceutical composition comprising compound E, or a pharmaceutically acceptable salt or solvate thereof: nicotinic acid or a pharmaceutically acceptable salt or solvate thereof, and an HMG Co-A reductase inhibitor in combination with a pharmaceutically acceptable carrier. The patent contains 5 more patent claims.
priorityDate 2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557067

Total number of triples: 35.